Related Experiment Video
Updated: Apr 5, 2026

Assembly and Purification of Prototype Foamy Virus Intasomes
Published on: March 19, 2018
Vorinostat-An Overview
1Consultant Dermatologist, Kedar Hospital, Chennai, Tamil Nadu, India.
Abstract:
Vorinostat is a new drug used in the management of cutaneous T cell lymphoma when the disease persists, gets worse or comes back during or after treatment with other medicines. It is an efficacious and well tolerated drug and has been considered a novel drug in the treatment of this condition. Currently apart from cutaneous T cell lymphoma the role of Vorinostat for other types of cancers is being investigated both as mono-therapy and combination therapy.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Pharmacokinetics: Overview
Therapeutic Drug Monitoring: Overview and Classification
Biopharmaceutics and Pharmacokinetics: Overview